Results 161 to 170 of about 3,981,458 (213)

Efficacy and safety of avatrombopag in the treatment of chemotherapy-induced thrombocytopenia in children with acute lymphoblastic leukemia: a single-center retrospective study. [PDF]

Ther Adv Hematol
Yang H, Gao J, Ruan Y, Chen Z, Fang R, Zhang L, Wang Z, Yi T, Zhang Q, Luo Y, Chen L, Wu X.   +11 more
europepmc   +1 more source

Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies. [PDF]

J Gastrointest Cancer
Li J, Wang W, Jiang K, Cui J, Wang C, Liang T, Wang Y, Liu S, Zhou W.   +8 more
europepmc   +1 more source

Effectiveness of partial splenic embolization in colorectal cancer patients with chemotherapy-induced thrombocytopenia: results of a single institution retrospective study. [PDF]

Front Oncol
Li D, Peng T, Wu KT, Huang YT, Liu Y, Wan Y, Zhang B.   +6 more
europepmc   +1 more source

Erratum: A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors [Corrigendum]. [PDF]

Int J Gen Med, 2022
europepmc   +1 more source

Chemotherapy-induced thrombocytopenia and platelet transfusion in patients with diffuse large B-cell lymphoma. [PDF]

Transl Cancer Res, 2020
Lu R, Lin Q, Chen S, Ye X.
europepmc   +1 more source

Role of thrombopoietin receptor agonists in chemotherapy-induced thrombocytopenia: A meta-analysis. [PDF]

J Oncol Pharm Pract
Gurumurthy G, Kisiel F, Gurumurthy S, Gurumurthy J.   +3 more
europepmc   +1 more source

Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study. [PDF]

Ther Adv Med Oncol
Qin S, Wang Y, Yao J, Liu Y, Yi T, Pan Y, Chen Z, Zhang X, Lu J, Yu J, Zhang Y, Cheng P, Mao Y, Zhang J, Fang M, Zhang Y, Lv J, Li R, Dou N, Tang Q, Ma J.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical Challenges and Promising Therapies for Chemotherapy-Induced Thrombocytopenia

Expert Review of Hematology, 2021
Introduction: Chemotherapy-induced thrombocytop enia (CIT) is a common complication of cancer treatment causing chemotherapy delays, dose reductions, and treatment discontinuation, negatively impacting treatment outcomes and putting patients at risk for bleeding complications.
Hanny Al-Samkari, Gerald A Soff
exaly   +3 more sources